News about PaperPanda, Open Access, and Research
Our bodies connect us to the world. When people lose parts of their bodies to disease or traumatic injury, they often feel that they’ve lost a part of who they are, even experiencing a grief akin to losing a loved one. Their sense of personal loss is justified because unlike salamanders or snarky comic … Read more
A network of clinics has been set up to give treatments to people who are extremely vulnerable to the coronavirus soon after they have a positive test Health 27 January 2022 By Clare Wilson Sotrovimab is an antibody treatment that is given as an infusion ice_blue/Shutterstock As the UK phases out covid-19 restrictions – with … Read more
A widely-used cancer drug that works on the immune system could push HIV out of hiding, potentially leaving the virus open to being attacked and eliminated, according to promising results from a small new study. HIV (human immunodeficiency virus) almost needs no introduction: the virus is notorious for its ability to evade the immune … Read more
An existing cancer drug has been found to also wake up dormant HIV, and it could eventually work with an HIV medicine in a “kick and kill” strategy Health 26 January 2022 By Clare Wilson The pembrolizumab monoclonal antibody drug protein molekuul.be / Alamy Stock Photo Today, HIV can be kept under control, but for … Read more
A new drug with the potential to treat endometriosis-associated pain with very few side effects is getting closer to official approval. Endometriosis is a chronic inflammatory condition and the leading cause of pelvic pain worldwide. With no known cause or cure, many patients have run out of options and are living with chronic and unrelenting symptoms. … Read more
By Clare Wilson A participant in a clinical trial for aducanumab Kayana Szymczak/New York Times/Redux/eyevine EXPECT to see debate over a new medicine to treat Alzheimer’s disease, called aducanumab, continue into 2022. Approved in the US last June, it is the first drug designed to treat a possible cause of this form of dementia, rather than the symptoms. … Read more
The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization for the potent oral antiviral regimen developed by Pfizer to treat COVID-19, making it just the second such drug to receive a regulatory greenlight by any country. Last month, the United Kingdom authorized the use of a Merck-made pill that appears much … Read more
The world’s first injectable medication to reduce the risk of acquiring HIV has been approved by the Food and Drug Administration (FDA), the agency announced Monday (December 20). The injectable drug – called Apretude or its generic name, “cabotegravir extended-release injectable suspension” – provides an alternative to daily pills for HIV prevention, such as Truvada and Descovy. These pills are … Read more